000			05337cam a2200445Mi 4500
001			96131
003			ES-MaUEC
005			20230102112739.0
006			m o d
007			cr |n|||||||||
008			170605s2017 sz o 000 0 eng d
020			_a3319575201 _q(electronic bk.)
020			_a9783319575209 _q(electronic bk.)
020			_z3319575198
020			_z9783319575193
040			_aYDX _cYDX _dN$T _dGW5XE _dEBLCP _dUAB _dYDX _dESU _dAZU _dUPM _dOCLCF _dIOG _dCOO _dMERER _dOCLCQ _dU3W _dMERUC _dES-MaUEC _bspa
050		4	_aRC312.5.E9 _b2017 EB
066			_c(S
245	0	0	_aOcular tuberculosis _cAtul Kumar, Rohan Chawla, Namrata Sharma, editors.
264		1	_aCham, Switzerland _bSpringer International Publishing _c2017
300			_a1 recurso en línea
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_atext file _bPDF
490	0		_aEssentials in ophthalmology
505	0		_6880-01 _aPreface; Contents; Contributors; 1: Epidemiological Aspect of Ocular Tuberculosis; Introduction; Epidemiology of Ocular TB in Patients with Pulmonary TB; Ocular TB in Developed Countries; Ocular TB in Developing Countries; Ocular TB in the Immunocompromised; Gender; Laterality; Anatomical Location of Ocular TB; Conclusion; References; 2: Pathogenesis and Pathology of Ocular Tuberculosis; Pathology of Ocular Tuberculosis; Pathogenesis of Ocular Tuberculosis; Immunopathogenesis of Ocular Tuberculosis (Fig. 2.7); Cellular Immunity to MTB.
505	8		_aClinical Spectrum of Intraocular Tuberculosis Diagnostic Challenge; Anterior Uveitis; Investigations; Management; Intermediate Uveitis; Posterior Uveitis; Clinical Manifestations of Posterior Segment Tuberculosis; Choroidal Tubercles; Choroidal Tuberculomas; Serpiginous Choroiditis; Points Favouring an Autoimmune Aetiology; Points Against Autoimmune Aetiology; Points Favouring Tubercular Aetiology; Points Against Tubercular Aetiology; Tubercular Endophthalmitis and Panophthalmitis; References; 8: Tubercular Multifocal Serpiginoid Choroiditis; Introduction.
505	8		_aSide Effects of ATT Therapy [4, 5] Novel Drug Delivery System for Antitubercular Treatment; Role of Steroids and Immunosuppressives; Factor Associated with Poor Visual Outcome [5]; Treatment of Drug-Resistant TB; New Technologies for Tuberculosis Control: A Framework for Their Adoption, Introduction and Implementation (Geneva, World Health Organization, 2007); Newer Drugs; Treatment of Ocular Tuberculosis in Immunocompromised Patients; Treatment of Ocular Tuberculosis in Paediatric Patients; Conclusions; References; 7: Tubercular Uveitis; Introduction.
520	3		_aA concise guide for ophthalmologists detailing tuberculosis, which can cause disease in multiple organs throughout the body, including the eye. Tuberculosis is an infection caused by Mycobacterium tuberculosis. It can affect any part of the eye (intraocular, superficial or surrounding the eye), with or without presence of systemic involvement. Difficulty in obtaining adequate ocular tissue for histopathological and microbiological analysis makes it difficult to conclusively establish a diagnosis of tuberculosis in ocular disorders. Ocular Tuberculosis is a text devoted to in-depth coverage of this topic. Written and edited by international leaders in the field, discussing detailed and practical information on everything from clinical features, ocular imaging studies, and pathology, to investigations, treatment and surgical management of this disease, Ocular Tuberculosis is a truly comprehensive text.
650		7	_aOjos _xTuberculosis. _2embne _0(OCoLC)fst00919211 _0 _9139188
700	1		_aChawla, Rohan, _eeditor literario
700	1		_aKumar, Atul, _eeditor literario
700	1		_aSharma, Namrata, _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-57520-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
880	8		_6505-00/(S _aRecent Advances in the Diagnosis of Ocular TBReferences; 3: Imaging Studies for Ocular Tuberculosis; Fundus Fluorescein Angiography; Indocyanine Green (ICG) Angiography; Fundus Autofluorescence; Optical Coherence Tomography (OCT); Ultrasonography; References; 4: Laboratory and Radiological Investigations in the Diagnosis of Ocular Tuberculosis; Introduction; Investigations; Molecular Assays; Imaging; Diagnostic Approach; References; 5: Tuberculin Skin Test and Interferon-γ Release Assays in the Diagnosis of Ocular Tuberculosis; Introduction; Tuberculin Skin Test (TST).
880	8		_6505-01/(S _aInterferon-γ Release Assays (IGRAs) Comparison of IGRAs with the TST; Choosing Between the T-SPOT. TB and QFT; Approach to the Diagnosis of Ocular Tuberculosis; Common Diagnostic Strategies; Other Techniques; Direct Evidence; Acid-Fast Smear; Culture of Intraocular Fluid/Tissue; Histopathologic Examination; Polymerase Chain Reaction; Imaging; Conclusion; References; 6: Management of Ocular Tuberculosis; Introduction; Ocular Tuberculosis; Challenges in Management of Ocular Tuberculosis; Pharmacokinetics and Pharmacodynamics of Anti-TB Drugs; Treatment; Monitoring of Response.
988			_aSpringer_Medicine_2017
998			_b02/2018 _dz _e- _zSI
999			_c96131 _d96131 _x1